Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia

Molecular Medicine

Volumn 15, Issue 5-6, 2009, Pages 152-159

  Loomans, Cindy J M ^a,b   Van Haperen, Rien ^b   Duijs, Jacques M ^a   Verseyden, Caroline ^a   De Crom, Rini ^b   Leenen, Pieter J M ^b   Drexhage, Hemmo A ^b   De Boer, Hetty C ^a   De Koning, Eelco J P ^a   Rabelink, Ton J ^a   Staal, Frank J T ^b   Van Zonneveld, Anton Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; INTERLEUKIN 12P40; INTERLEUKIN 12P70;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOCYTOSIS; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HYPERGLYCEMIA; INFLAMMATION; MACROPHAGE; MIXED LYMPHOCYTE REACTION; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; T LYMPHOCYTE ACTIVATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERGLYCEMIA; MICE; MICE, INBRED C57BL; PHENOTYPE; STEM CELLS; STREPTOZOCIN; UMBILICAL CORD;

EID: 66449087109     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00032     Document Type: Article

References (45)

1. Abaci A, et al.(1999) Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation99:2239-42.
2. Sheetz MJ, King GL. (2002) Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA288:2579-88.
3. Waltenberger J. (2001) Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc.Res.49:554-60.
4. Walter DH, et al.(2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation105:3017- 24.
5. Werner N, et al.(2002) Bone marrow-derived progenitor cells modulate vascular reendothelializa- tion and neointimal formation: effect of 3-hydroxy- 3-methylglutaryl coenzyme a reductase inhibition. Arterioscler. Thromb. Vasc. Biol.22:1567-72.
6. de Boer HC, et al.(2006) Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler. Thromb. Vasc. Biol.26:1653-9.
7. Asahara T, et al.(1999) Bone marrow origin of en- dothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res.85:221-8.
8. Kalka C, et al.(2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A.97:3422-7.
9. Loomans CJ, et al.(2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes53:195-9.
10. Tepper OM, et al.(2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation106:2781-6.
11. Krankel N, et al.(2005) Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler. Thromb. Vasc. Biol.25:698-703.
12. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA. (2000) Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest.106:571-8.
13. Tamarat R, et al.(2004) Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am. J. Pathol.164:457-66.
14. Fadini GP, et al.(2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol.45:1449-57.
15. Gadau S, et al.(2006) Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia49: 405-20.
16. Awad O, Jiao C, Ma N, Dunnwald M, Schatte- man GC. (2005) Obese diabetic mouse environment differentially affects primitive and mono-cytic endothelial cell progenitors. Stem Cells23:575-83.
17. Rosso A, et al.(2006) p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J. Biol. Chem.281:4339-47.
18. Asahara T, et al.(1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science275:964-7.
19. Fernandez PB, et al.(2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation65:287-300.
20. Rehman J, Li J, Orschell CM, March KL. (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation107:1164-9.
21. Romagnani P, et al.(2005) CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ. Res.97:314-22.
22. Heil M. Schaper W. (2004) Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ. Res.95:449-58.
23. Grunewald M, et al.(2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell124:175-89.
24. Urbich C, et al.(2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation108:2511-6.
25. Loomans CJ, et al.(2006) Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression. Arterioscler. Thromb. Vasc. Biol.26:1760-7.
26. de Bruijn MF, et al.(1994) Distinct mouse bone marrow macrophage precursors identified by differential expression of ER-MP12 and ER-MP20 antigens. Eur. J. Immunol.24:2279-84.
27. Nikolic T, de Bruijn M.F, Lutz MB, Leenen PJ. (2003) Developmental stages of myeloid dendritic cells in mouse bone marrow. Int. Immunol.15:515-24.
28. Cipolletta C, Ryan KE, Hanna EV, Trimble ER. (2005) Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes54:2779-86.
29. Devaraj S, et al.(2006) Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes55:774-9.
30. van der Loo JC, Slieker WA, Kieboom D, Ploemacher RE. (1995) Identification of hematopoietic stem cell subsets on the basis of their primitiveness using antibody ER-MP12. Blood85:952-62.
31. Jaffe EA, Nachman RL, Becker CG, Minick CR. (1973) Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J. Clin. Invest.52:2745-56.
32. Davignon J, et al.(2004) Beneficial cardiovascular pleiotropic effects of statins. Circulation109:III39-43.
33. Dimmeler S, et al.(2001) HMG-CoAreductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest.108:391-7.
34. Llevadot J, et al.(2001) HMG-CoAreductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J. Clin. Invest.108:399- 405.
35. Fuhrman B, et al.(2002) Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating mono- cytes. Atherosclerosis164:179-85.
36. Vamvakopoulos JE, Green C. (2003) HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection. BMC Cardiovasc. Disord.3:6
37. Ii M, et al.(2006) Endothelial progenitor throm- bospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ. Res.98:697-704.
38. Loomans CJ, de Koning EJ, Staal FJ, Rabelink TJ, Zonneveld AJ. (2005) Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress? Antioxid. Redox. Signal7:1468-75.
39. Silvestre JS, et al.(2003) Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition. Circulation108:2839- 42.
40. Assmus B, et al.(2002) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation106:3009-17.
41. Tateishi-Yuyama E, et al.(2002) Therapeutic an- giogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet360:427-35.
42. Fogg DK, et al.(2006) A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science311:83-7.
43. Lehtonen A, et al.(2005) Differential expression of IFN regulatory factor 4 gene in human mono- cyte-derived dendritic cells and macrophages. J. Immunol.175:6570-9.
44. Fu J, Tay SS, Ling EA, Dheen ST. (2006) High glucose alters the expression of genes involved in proliferation and cell-fate specification of embryonic neural stem cells. Diabetologia49:1027-38.
45. Vasa M, et al.(2001) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation103:2885-90.